EUVIMEDEUVIMED entdecken
Crossref

Silver‐Doped PCL‐Silk Fibroin Electrospun Nanofibrous Scaffolds with Synergistic Osteogenic and Antimicrobial Activity

Debolina Saha, Piyali Basak iD, Subhadip Bodhak iD

ChemBioChem · 14.05.2026 · 27 (9)

DOI: 10.1002/cbic.202500961 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, online erschienen am 10.05.2026. Verfasst von Debolina Saha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biomaterials and Medical Devices Division, CSIR-Central Glass and Ceramic Research Institute, Kolkata, India. Hauptthemen laut MEDLINE: Fibroins, Silver, Nanofibers, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Science and Engineering Research Board, Central Glass and Ceramic Research Institute, SERB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study reports the fabrication and comprehensive characterizations of silver nanoparticles (AgNPs)‐doped polycaprolactone‐silk fibroin (PCL‐SF) scaffolds designed to combine cytocompatibility with osteogenic and antibacterial functions pertinent to bone regeneration. SF derived from Bombyx mori cocoons was blended with PCL, and AgNPs were incorporated at trace doping concentrations (0.05–0.1% w/v) to establish a specific therapeutic window in PCL‐SF electrospun nanofibrous scaffolds to optimize the balance between strong osteogenic and antibacterial activity. Successful SF isolation was confirmed by FTIR, X‐ray diffraction (XRD), and sodium dodecyl sulphate‐polyacrylamide gel electrophoresis (SDS‐PAGE) analyses. All nanofiber (NF) groups exhibited uniform morphologies with diameters ranging from 228 to 329 nm. The optimized PCL‐SF‐0.1% Ag groups showed enhanced tensile strength (69%) when compared with PCL‐SF, along with improved hydrophilicity, reduced from 106° to 61° compared to pure PCL. This was accompanied by a controlled degradation profile, with weight loss increasing from 12.66% (PCL) to 21.6% and a corresponding rise in swelling ratio from 11.24% to 33.78%. Evidently, significant inhibition of Escherichia coli ∼ 48.24% and Staphylococcus aureus ∼ 46.26% and prominent ZOI along with superior bone cell proliferation and alkaline phosphatase activity confirm that enhanced osteogenesis could be achieved for PCL‐SF‐0.1% Ag NFs. Collectively, the dual‐action efficacy of AgNP‐doped PCL‐SF scaffolds underscores their potential in repairing infected bone defects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroinsSilverNanofibersAnti-Bacterial AgentsOsteogenesisPolyestersTissue ScaffoldsEscherichia coliAnimalsStaphylococcus aureusMicrobial Sensitivity TestsBombyxMetal NanoparticlesCell Proliferation

Stichwörter der Autor:innen

Bombyx moriAgNPs dopingPCL‐SFantibacterialelectrospun nanofiberosteogenesissilk fibroin

Substanzen

FibroinsSilverAnti-Bacterial AgentspolycaprolactonePolyesters

Autor:innen und Institutionen

  • Biomaterials and Medical Devices Division, CSIR-Central Glass and Ceramic Research Institute, Kolkata, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
  • School of Bioscience and Engineering, Jadavpur University, Kolkata, India.

ORCID-Profile: Piyali Basak, Subhadip Bodhak

Förderung

  • Science and Engineering Research Board
  • Central Glass and Ceramic Research Institute
  • SERB
  • CGCRI

Zitieren

APA

Saha, D., Basak, P., & Bodhak, S. (2026). Silver‐Doped PCL‐Silk Fibroin Electrospun Nanofibrous Scaffolds with Synergistic Osteogenic and Antimicrobial Activity. ChemBioChem, 27(9). https://doi.org/10.1002/cbic.202500961

Vancouver

Saha D, Basak P, Bodhak S. Silver‐Doped PCL‐Silk Fibroin Electrospun Nanofibrous Scaffolds with Synergistic Osteogenic and Antimicrobial Activity. ChemBioChem. 2026;27(9). doi:10.1002/cbic.202500961

BibTeX
@article{Saha2026,
  author = {Saha, Debolina and Basak, Piyali and Bodhak, Subhadip},
  title = {Silver‐Doped PCL‐Silk Fibroin Electrospun Nanofibrous Scaffolds with Synergistic Osteogenic and Antimicrobial Activity},
  journal = {ChemBioChem},
  year = {2026},
  volume = {27},
  number = {9},
  doi = {10.1002/cbic.202500961}
}
Kostenlos starten →